VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Financials anyone? Cash runway?

<< Previous

Bullboard Posts

Next >>

Comment by G1945Von Sep 03, 2024 9:38am

99 Views

Post# 36205959

RE:RE:RE:RE:RE:RE:RE:RE:RE:Financials anyone? Cash runway?

PlasticOno wrote: GrahamB, what in your opinion are the reasons why up to this date there are hardly andy sales and revenue in spite of a promising product that is easyier to handle and significantly reducing costs for clinics?

My 2 cents:

They developed a promising product, with cMRI level accuracy. It's having problems with creating widespread awareness. The medical field creatures of habit, is hanging on to the old ways and won't rush to adapt to new ways, sticking with what they know best for now, old school mentality. Building a brand takes time and money. VMS+ would reduce costs but the initial investment may not be affordable for small institutions. They will need to sell to small institutions for volume sales. It's portable so it should be easy to sell, compared to the huge and very expensive cMRI, and it does not require general anesthesia It's an Echcardiagrphy A.I. alternative and much, much cheaper. It's a much more practical Echo for Pediatric patients, which is a big plus. VMS+ in my opinion is a buy-and-hold. If you don't believe in it at this stage move on and put your money elsewhere.

GLTA
G1945V

<< Previous

Bullboard Posts

Next >>

FLYHT and WestJet partner on weather forecasting